Beverly Isherwood

Beverly Isherwood

Bev, Partnership Lead at Medicines Discovery Catapult, has responsibility for the development and delivery of a portfolio of cross-sector collaborations aimed at accelerating medicines discovery for infectious disease. Bev is a member of the CF AMR Syndicate management team – an initiative jointly managed by MDC, The Cystic Fibrosis Trust and LifeArc which aims to bring forward guidance, resources and push funding to catalyse an antimicrobial pipeline that can address the needs of people with Cystic Fibrosis. Bev has 15 year’s experience in drug discovery working in or at the interface with private, public and charity sectors to advance R&D for patient impact.